➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Baxter
AstraZeneca
Moodys

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Celltrion Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?

CELLTRION has seventeen approved drugs.



Drugs and US Patents for Celltrion

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Celltrion PREGABALIN pregabalin CAPSULE;ORAL 212865-002 Mar 20, 2020 AB RX No No   Start Trial   Start Trial
Celltrion PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 076798-001 Oct 26, 2012 AB RX No No   Start Trial   Start Trial
Celltrion LAMOTRIGINE lamotrigine TABLET;ORAL 078982-002 Jan 27, 2009 DISCN No No   Start Trial   Start Trial
Celltrion RISPERIDONE risperidone TABLET;ORAL 078871-001 Oct 9, 2008 AB RX No No   Start Trial   Start Trial
Celltrion MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 090073-001 Sep 4, 2015 AB RX No No   Start Trial   Start Trial
Celltrion LEVOFLOXACIN levofloxacin TABLET;ORAL 090367-003 Jun 20, 2011 AB RX No No   Start Trial   Start Trial
Celltrion PREGABALIN pregabalin CAPSULE;ORAL 212865-001 Mar 20, 2020 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Dow
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.